From Targets to Treatments: Bridging Autoimmune Research to Advance Understanding of Alopecia Areata
November 2015
in “
The journal of investigative dermatology. Symposium proceedings/The Journal of investigative dermatology symposium proceedings
”
New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide → Studysummary This paper discusses the role of the National Alopecia Areata Foundation in advancing research on alopecia areata, emphasizing genetic and immunological factors, and reports no new clinical findings.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
Alopecia areata, affecting over 146 million people globally, is an autoimmune disease causing hair loss. The National Alopecia Areata Foundation (NAAF), established in 1981, supports research, patient support, and public education. NAAF's biennial research summits, part of the Alopecia Areata Treatment Development Program, have significantly shifted the understanding of the disease from inflammatory and dermatological views to recognizing genetic and immunological factors as key drivers.
